Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation

Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment. However, the limited information on BA pathophysiology makes valuable any experience in disease management. This study aimed to analyze the evolution and survival of patients with BA referred for HPE (Kasai operation) in our department. Materials and Methods: A retrospective analysis was performed on fourteen patients with BA, diagnosed in the pediatric department and further referred for HPE in our surgical department between 2010 and 2016. After HPE, the need for transplantation was assessed according to patients cytomegalovirus (CMV) status, and histological and biochemical analysis. Follow-up results at 1–4 years and long term survival were assessed. Results: Mean age at surgery was 70 days. Surgery in patients younger than 60 days was correlated with survival. Jaundice’s clearance rate at three months was 36%. Total and direct bilirubin values had a significant variation between patients with liver transplants and native liver (p = 0.02). CMV was positive in eight patients, half with transplant need and half with native liver survival. Smooth muscle actin (SMA) positivity was proof of advanced fibrosis. The overall survival rate was 79%, with 75% for native liver patients and an 83% survival rate for those with liver transplantation. Transplantation was performed in six patients (43%), with a mean of 10 months between HPE and transplantation. Transplanted patients had better survival. Complications were diagnosed in 63% of patients. The mean follow-up period was six years. Conclusions: HPE, even performed in advanced cirrhosis, allows a significant survival, and ensures an essential time gain for patients requiring liver transplantation. A younger age at surgery is correlated with a better outcome, despite early CMV infection.

[1]  G. Tiao,et al.  Innate Immunity and Pathogenesis of Biliary Atresia , 2020, Frontiers in Immunology.

[2]  B. Shneider,et al.  60 Days in Biliary Atresia: A Historical Dogma Challenged , 2020, Clinical liver disease.

[3]  K. Dong,et al.  Risk Factors and Prognostic Effects of Cholangitis after Kasai Procedure in Biliary Atresia Patients: A Retrospective Clinical Study. , 2019, Journal of pediatric surgery.

[4]  W. Hardikar,et al.  Normal Gamma Glutamyl Transferase Levels at Presentation Predict Poor Outcome in Biliary Atresia. , 2019, Journal of pediatric gastroenterology and nutrition.

[5]  P. Tam,et al.  Determining the optimal timing of liver transplant for pediatric patients after Kasai portoenterostomy based on disease severity scores. , 2019, Journal of pediatric surgery.

[6]  H. Hsu,et al.  Bilirubin level 1 week after hepatoportoenterostomy predicts native liver survival in biliary atresia , 2019, Pediatric Research.

[7]  M. J. Maisels,et al.  Association of Early Direct Bilirubin Levels and Biliary Atresia Among Neonates , 2019, JAMA network open.

[8]  F. Karrer,et al.  Error traps and culture of safety in biliary atresia. , 2019, Seminars in pediatric surgery.

[9]  P. Vidigal,et al.  MULTIVARIATE ANALYSIS OF BILIARY FLOW-RELATED FACTORS AND POST-KASAI SURVIVAL IN BILIARY ATRESIA PATIENTS. , 2019, Arquivos de gastroenterologia.

[10]  S. Ekinci,et al.  Revisiting long-term prognostic factors of biliary atresia: A 20-year experience with 81 patients from a single center. , 2019, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[11]  R. Wells,et al.  Recent advances in understanding biliary atresia , 2019, F1000Research.

[12]  M. Khedr,et al.  Biliary atresia recent insight , 2018 .

[13]  P. Tam,et al.  Long-term Results and Quality of Life Assessment in Biliary Atresia Patients: A 35-Year Experience in a Tertiary Hospital , 2017, Journal of pediatric gastroenterology and nutrition.

[14]  C. Paidas,et al.  Biliary Atresia: Epidemiology, Genetics, Clinical Update, and Public Health Perspective. , 2017, Advances in pediatrics.

[15]  Gong Chen,et al.  Surgical outcome and etiologic heterogeneity of infants with biliary atresia who received Kasai operation less than 60 days after birth , 2017, Medicine.

[16]  C. Y. Ooi,et al.  Early and Peri-operative Prognostic Indicators in Infants Undergoing Hepatic Portoenterostomy for Biliary Atresia: a Review , 2017, Current Gastroenterology Reports.

[17]  N. Hadžić,et al.  Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition , 2017, Journal of pediatric gastroenterology and nutrition.

[18]  M. Girard,et al.  Biliary atresia: Clinical advances and perspectives. , 2016, Clinics and research in hepatology and gastroenterology.

[19]  Sara C. Fallon,et al.  Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia , 2016, Journal of pediatric gastroenterology and nutrition.

[20]  P. Rosenthal,et al.  Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. , 2016, The Journal of pediatrics.

[21]  M. Davenport,et al.  Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy , 2015, Pediatric Surgery International.

[22]  M. Davenport,et al.  Cytomegalovirus-associated biliary atresia: An aetiological and prognostic subgroup. , 2015, Journal of pediatric surgery.

[23]  A. Allam,et al.  Design and validation of a diagnostic score for biliary atresia. , 2014, Journal of hepatology.

[24]  A. Németh,et al.  Early cytomegalovirus infection and the long‐term outcome of biliary atresia , 2009, Acta paediatrica.

[25]  Xian-min Xiao,et al.  Relationship between prognosis of biliary atresia and infection of cytomegalovirus , 2008, World journal of pediatrics : WJP.